A case-control evaluation of treatment efficacy: The example of magnesium sulfate prophylaxis against eclampsia in patients with preeclampsia

Journal of Clinical Epidemiology

Volumn 50, Issue 4, 1997, Pages 419-423

  Abi Said, Dima ^a,d   Annegers, John F ^a   Combs Cantrell, Deborah ^b   Suki, Rabih ^a   Frankowski, Ralph F ^a   Willmore, L James ^c  

^a UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF TEXAS   (United States)

Author keywords

Case control; Eclampsia; Preeclampsia; Prophylaxis; Randomized trial; Risk factors

Indexed keywords

ANTICONVULSIVE AGENT; MAGNESIUM SULFATE;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DELIVERY; DRUG EFFICACY; ECLAMPSIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PREECLAMPSIA; PRIORITY JOURNAL; REGRESSION ANALYSIS; RISK FACTOR; TREATMENT OUTCOME; UNITED STATES;

ADULT; BIAS (EPIDEMIOLOGY); CASE-CONTROL STUDIES; DISEASE PROGRESSION; ECLAMPSIA; EVALUATION STUDIES; FEMALE; HUMANS; LOGISTIC MODELS; MAGNESIUM SULFATE; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; TOCOLYTIC AGENTS; TREATMENT OUTCOME;

EID: 0030983155     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(96)00421-0     Document Type: Article

References (12)

1. Selby JV. Case-control evaluations of treatment and program efficacy. Epidemiol Rev 1994; 16: 90-101.
2. Horwirz RI, Feinstein AR. The application of therapeutic-trial principles to improve the design of epidemiologic research: A case-control study suggesting that anticoagulants reduce mortality in patients with myocardial infarction. J Chronic Dis 1981; 34: 575-581
3. Horwitz RI, Feinstein AR. Improved observational method for studying therapeutic efficacy: Suggestive evidence that lidocaine prophylaxis prevents death in acute myocardial infarction. JAMA 1981; 246: 2455-2459.
4. Psaty BM, Koepsell TD, LoGerfo JP, et al Beta-blockers and primary prevention of coronary heart disease in patients with high blood pressure. JAMA 1989; 261: 2087-2094.
5. Van der Meer JT, Van Wijk W, Thompson J, et al. Efficacy of antibiotic prophylaxis for prevention of native-valve endocarditis. Lancet 1992; 339: 135-139.
6. Imperiale TF, Horwitz RI. Does prophylaxis prevent postdental infective endocarditis? A controlled evaluation of protective efficacy. Am J Med 1990; 88: 131-136.
7. Chesley LC. A survey of management and case mortality. In: Chesley LC, Ed. Hypertensive Disorders of Pregnancy. New York: Appleton-Century-Crofts; 1978: pp. 309-340.
8. Lucas MJ, Leveno KJ, Cunningham G. A comparison of magnesium sulfate with phenytoin in the prevention ot eclampsia. N Engl J Med 1995; 333: 201-205.
9. Hughes EC. Obstetric-Gynecologic Terminology. Philadelphia: Davis; 1972.
10. Grimson RC, DalCorso D, Kennedy B, et al. A Computer Program for the Analysis of Case-Control Studies (CASCNTRL). Chapel Hill, NC: The Institute of Statistics; 1980.
11. Hosmer DW, Lemeshow S. Applied Logistic Regression. New York: John Wiley & Sons; 1989.
12. Computing Resource Center. Stata Reference Manual. Release 3, 5th Edition. Santa Monica, CA; 1992.